10 | CFHN centralfloridahealthnews.com While that increase is enough to get the at- tention of researchers and physicians, Wat- son Clinic’s Dr. Elisabeth Dupont says it has not translated into a dramatic shift in what she sees day to day. “Because the rate of increase has been slow and low, I have not really appreciated a ma- jor change,” she says. “I have always had young patients. Dupont recalls treating a 25-year-old about 20 years ago who is still doing well today. What has changed, Dupont says, is how much attention breast cancer in younger women receives. “I would guess in the past 10 years, it has been more on my mind,” she says. DIFFERENT AGES, DIFFERENT CHALLENGES Breast cancer at a younger age can differ from breast cancer diagnosed later in life. Dupont says younger patients are more likely to be diagnosed with aggressive sub- types, including triple-negative, HER2-posi- tive and hormone-negative breast cancers. Screening also presents a set of its own challenges. Most women younger than 40 are not yet undergoing routine mammog- raphy, and younger women frequently have dense breast tissue, which can make it more difficult to detect cancer on mammograms. In addition, Dupont says high-risk surveil- lance programs have become more com- mon, along with an overall greater public awareness. “Today we talk about it, where in the past it was taboo,” she says. Younger women may also experience con- cerns that differ from those of older breast cancer patients. Treatment can affect fer- tility and can also potentially contribute to early menopause or sexual dysfunction. Many of the younger patients are also rais- ing children and building careers for them- selves. Navigating financial responsibilities is another obstacle they grapple with while undergoing treatment. In addition, Dupont adds, younger breast cancer survivors have a higher prevalence of psychosocial issues, such as anxiety and depression. KNOW YOUR PERSONAL RISK While family history matters, Dupont says genetics play a smaller role than what many assume. “Genetic influence is not as common as people think,” she says. “Still, most people with breast cancer do not carry a gene.” She adds that if a younger patient has a strong family history of breast or ovarian cancer or genetic mutations associated with breast cancer, she recommends closer monitoring or earlier screening. Dupont says many experts recommend ADVERTORIAL HEART NEWS M icroplastics and nano- plastics are increasing your cardiovascular risk. The production of plastics is constantly increasing and this is set to continue through 2050. Plastics can permeate the environment by way of ocean currents, atmospheric winds and terrestrial phenomena, contributing to their widespread distribution. Once released into nature, plastics are susceptible to degradation, leading to the formation of microplastics, defined as particles smaller than 5 mm, and nanoplastics, defined as particles smaller than 1000 nanometers. Both types of particles trigger a range of toxic effects. Several research studies have shown that microplastics and nanoplastics (MNPs) enter the human body through eating, breathing, and skin exposure, where they interact with tissues and organs. MNPs have been found in selected human tissues, such as the placenta, lungs, and liver, as well as in breastmilk, urine, and blood. Recent studies performed in preclinical settings have led to the suggestion of MNPs as a new risk factor for cardiovascular diseases. They do this by promoting oxidative stress, inflammation, and programmed cell death in endothelial and other vascular cells in the blood vessels. Studies done in animals showed that MNPs change the heart rate and cause impairment of heart function, fibrosis in heart muscles, and remote dysfunction of blood vessel cells. Recent studies have shown there is an association between the burden of MNPs and cardiovascular disease. Atherosclerotic plaque was detected in surgical samples from the carotid artery. Subsequent studies confirmed that patients with MNPs in the plaque in their carotid artery had a higher risk of having a heart attack, stroke, or death from any caus e compared to patients whose carotid artery sample did not have MNPs in the plaque. BIO: Dr. Kollagunta Chandrasekhar, better known as Dr. Sekhar (pronounced Shaker) has been practicing cardiology in Winter Haven for more than 25 years. This column is sponsored by KSC Cardiology, and the opinions expressed herein may not reflect those of CFHN or of its advertisers. DR. RITU APARAJITA KSC Cardiology Microplastics Pose Growing Threat to Heart Health EDITION FEATURE Watson Clinic Doctor Discusses Increase in Diagnoses in Younger Women by SHAYLYNN MARKS B reast cancer is far more common in older women, but data from the most recent decade of data shows diagnoses among women younger than 50 have been slowly increasing by about 1.4% each year. Breast Cancer Before 50
View this content as a flipbook by clicking here.